A phase 2, open-label, single arm trial to evaluate the shedding and safety of CAIV-T administered to children 6 to less than 60 months of age.

Trial Profile

A phase 2, open-label, single arm trial to evaluate the shedding and safety of CAIV-T administered to children 6 to less than 60 months of age.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors MedImmune
  • Most Recent Events

    • 29 Oct 2010 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 29 Oct 2010 Additional lead trial investigator (Raburn Mallory) identified as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top